← Open Payments lookup

AHMED TARANISSI: Open Payments

NPI 1215978689 · MEXICO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$65,652 in 252 payments from 15 companies in 2025. Trend: 2023 $46,736 · 2024 $59,292 · 2025 $65,652

Speaker / faculty: $38,960Honoraria: $10,450Consulting: $9,700Food & beverage: $4,465Travel & lodging: $2,069Education: $9
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.54$23,689
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$20,667
Axsome Therapeutics, Inc.22$10,998
Alkermes, Inc.39$8,440
Janssen Pharmaceuticals, Inc15$343
ABBVIE INC.18$311
Teva Pharmaceuticals USA, Inc.17$296
Otsuka America Pharmaceutical, Inc.21$239
Vanda Pharmaceuticals Inc.11$182
E.R. Squibb & Sons, L.L.C.10$148

Products named: INGREZZA, CAPLYTA, Auvelity, LYBALVI, INVEGA SUSTENNA, VRAYLAR, UZEDY, ARISTADA.

Industry payments across MO — which companies pay providers there.